All Programs

Use the tool below to view all available Global Oncology Academy Series

Managing Brain Metastases in ALK+ NSCLC
Managing Brain Metastases in ALK+ NSCLC
Project Oncology®
Managing Brain Metastases in ALK+ NSCLC
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
- Charles Turck, PharmD, BCPS, BCCCP
- Stacey Cohen, MD
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
On the Frontlines of Colorectal Cancer
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
- Ryan Quigley
- Samuel Muench, MD
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Project Oncology®
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
- Charles Turck, PharmD, BCPS, BCCCP
- Martin Dietrich, MD, PhD
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
AudioAbstracts
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
- Ryan Quigley
The Clinical Consequences of Delayed Colorectal Cancer Screening
The Clinical Consequences of Delayed Colorectal Cancer Screening
Clinician's Roundtable
The Clinical Consequences of Delayed Colorectal Cancer Screening
- Peter Buch, MD, FACG, AGAF, FACP
- Christopher Cann, MD
The Epigenetics of Lung Cancer Dormancy and Relapse
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®
The Epigenetics of Lung Cancer Dormancy and Relapse
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
0.25 credits
- Mariana C. Castells, MD, PhD
- Tsewang Tashi, MD
0.25 credits
Protecting Heart Health in Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
- Ryan Quigley
- Gregory Vidal, MD, PhD
The Past, Present, and Future of Metastatic Breast Cancer Care
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
The Past, Present, and Future of Metastatic Breast Cancer Care
- Ryan Quigley
- Gregory Vidal, MD, PhD
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Clinician's Roundtable
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Improving CRC Screening Uptake: An Integrated Approach
Improving CRC Screening Uptake: An Integrated Approach
Clinician's Roundtable
Improving CRC Screening Uptake: An Integrated Approach
- Mallik Greene, PhD
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstracts
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
- Ryan Quigley

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.